Article Details
Retrieved on: 2022-10-04 17:10:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Robust, highly consistent efficacy demonstrated in mCRPC both with or withouthomologous recombination repair gene mutations. Pfizer Inc. (NYSE: PFE) ...
Article found on: stockhouse.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here